4.7 Article

Enhanced Assessment of Perioperative Mortality Risk in Adults With Congenital Heart Disease

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 78, Issue 3, Pages 234-242

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2021.04.096

Keywords

clinical risk tool; congenital heart disease; perioperative risk; risk score

Funding

  1. Janssen-Cilag Limited
  2. British Heart Foundation
  3. Pfizer
  4. GlaxoSmithKline
  5. Bayer/Merck Sharp Dohme

Ask authors/readers for more resources

This study evaluated perioperative survival in adult congenital heart disease patients undergoing surgery in a large tertiary center and showed excellent discrimination ability of the PEACH risk score, which outperformed the ACHS score. A simple, 3-tiered risk stratification was established based on the PEACH score, demonstrating its utility in predicting in-hospital mortality after ACHD surgery.
BACKGROUND In-hospital mortality is a rare, yet feared complication following cardiac surgery in adult congenital heart disease (ACHD). A risk score, developed and validated in ACHD, can be helpful to optimize risk assessment. OBJECTIVES The purpose of this study was to assess the performance of EuroSCORE II components and procedu-rerelated Adult Congenital Heart Surgery (ACHS) score, identify additional risk factors, and develop a novel risk score for predicting in-hospital mortality after ACHD surgery. METHODS We assessed perioperative survival in patients aged >16 years undergoing congenital heart surgery in a large tertiary center between 2003 and 2019. A risk variable-derived PEACH (PErioperative ACHd) score was calculated for each patient. Internal and external validation of the model was undertaken, including testing in a validation cohort of patients operated in a second European ACHD center. RESULTS The development cohort comprised 1,782 procedures performed during the study period. Re-sternotomy was undertaken in 897 (50.3%). There were 31 (1.7%) in-hospital deaths. The PEACH score showed excellent discrimination ability (area under the curve [AUC]: 0.88; 95% CI: 0.83-0.94), and performed better than the ACHS score in our population (ACHS AUC: 0.69; 95% CI: 0.6-0.78; P = 0.0003). A simple 3-tiered risk stratification was formed: PEACH score 0 (in-hospital mortality 0.2%), 1-2 (3.6%), and >= 3 (17.2%). In a validation cohort of 975 procedures, the PEACH score retained its discriminative ability (AUC: 0.75; 95% CI: 0.72-0.77) and was well calibrated (Hosmer-Lemeshow chi-square goodness-of-fit P = 0.55). There was agreement in expected and observed perioperative mortality between cohorts. CONCLUSIONS The PEACH score is a simple, novel perioperative risk score developed and validated specifically for ACHD patients undergoing cardiac surgery. (C) 2021 the American College of Cardiology Foundation. Published by Elsevier. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available